Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Biogens pricey muscle drug Spinraza too costly for Britain

      Biogen's pricey muscle drug Spinraza too costly for Britain

      Ruby Khatun Khatun15 Aug 2018 9:45 AM IST
      LONDON: Biogen's muscle disease treatment Spinraza has been deemed too expensive for use on Britain's state-run health service, even after a price...
      Bayer shares fall 10 pct after Monsantos Roundup cancer trial

      Bayer shares fall 10 pct after Monsanto's Roundup cancer trial

      Ruby Khatun Khatun15 Aug 2018 9:30 AM IST
      FRANKFURT: Bayer shares plunged more than 10 percent after a California jury ordered the German company's newly acquired Monsanto subsidiary to pay...
      Bain Capital, Radiant Life care in race for buying Max Healthcare stake

      Bain Capital, Radiant Life care in race for buying Max Healthcare stake

      Ruby Khatun Khatun14 Aug 2018 5:28 PM IST
      Mumbai: After KKR backed Radiant Life Care, another private equity firm has entered into the fray to buy 47.5 percent stake in Max Healthcare from the...
      Telangana attracts over Rs 10,000 crore in Life Sciences in 4 years

      Telangana attracts over Rs 10,000 crore in Life Sciences in 4 years

      Ruby Khatun Khatun14 Aug 2018 11:00 AM IST
      Hyderabad: Telangana, already home to pharma majors such as Aurobindo Pharma and Dr Reddy's, attracted over Rs 10,000 crore investments in the life...
      Pharma exports to cross USD 19 billion in FY19: Pharmexcil

      Pharma exports to cross USD 19 billion in FY19: Pharmexcil

      Ruby Khatun Khatun14 Aug 2018 10:30 AM IST
      New Delhi: Pharmaceutical exports from the country are expected to cross USD 19 billion in worth during the current fiscal despite muted growth in the...
      Apollo Munich Health Insurance strengthens its foothold in West Bengal

      Apollo Munich Health Insurance strengthens its foothold in West Bengal

      Ruby Khatun Khatun14 Aug 2018 10:15 AM IST
      Durgapur: Apollo Munich Health Insurance announced its plans to strengthen its foothold in West Bengal with the opening of its branch office in...
      Orchard raises 150 million dollar to expand after GSK gene therapy deal

      Orchard raises 150 million dollar to expand after GSK gene therapy deal

      Ruby Khatun Khatun14 Aug 2018 10:00 AM IST
      LONDON: Anglo-American biotech company Orchard Therapeutics has raised a further $150 million (117.7 million pounds) to fund its work in gene therapy,...
      Insys to pay 150 million dollar to settle US opioid kickback probe

      Insys to pay 150 million dollar to settle US opioid kickback probe

      Ruby Khatun Khatun14 Aug 2018 10:00 AM IST
      Insys Therapeutics said it had reached a deal to pay at least $150 million to resolve a U.S. Justice Department investigation into claims that the...
      USFDA panel backs approval of Parateks antibiotic for pneumonia

      USFDA panel backs approval of Paratek's antibiotic for pneumonia

      Ruby Khatun Khatun14 Aug 2018 9:45 AM IST
      A U.S. Food and Drug Administration (USFDA) expert panel voted in favor of approval of Paratek Pharmaceuticals Inc’s antibiotic to treat bacterial...
      EU says second China company made tainted heart drug

      EU says second China company made tainted heart drug

      Ruby Khatun Khatun14 Aug 2018 9:30 AM IST
      FRANKFURT: The European Medicines Agency (EMA) said that a second Chinese contract manufacturer, Zhejiang Tianyu, had produced a common blood pressure...
      How can online pharmacies sell Medicines at Discount? Chemists ask drugs controller

      How can online pharmacies sell Medicines at Discount? Chemists ask drugs controller

      Ruby Khatun Khatun13 Aug 2018 5:56 PM IST
      Bengaluru: Discounts advertisement in media by online drug portals has raised concern among Karnataka state’s chemists with the latter raising...
      Glenmark Q1 net profit at Rs 232.99 crore

      Glenmark Q1 net profit at Rs 232.99 crore

      Ruby Khatun Khatun13 Aug 2018 11:00 AM IST
      New Delhi: Pharma major Glenmark Pharmaceuticals reported a consolidated net profit of Rs 232.99 crore in the first quarter ended June 30, 2018.The...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok